• JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator

ISSN (Print) 1013-9052
EISSN 1658-3558

The Saudi Dental Journal,
P.O. Box 52500,
Riyadh 11563,
Kingdom of Saudi Arabia
Tel.
966-1-467-7328
Fax.
933-1-467-7308 /
966-1-467-7534
Email
saudidj@ksu.edu.sa


Neurofibromatosis of the maxillofacial region


Khalid A. Al-Ruhaimi, BDS, MSc, Dr Med Dent*
Hermann F. Sailer, Dr Med, Dr Med Dent**
*Oral and Maxillofacial Surgery, Department of Biomedical Dental SciencesCollege of Dentistry, King Saud University
**Oral and Maxillofacial Surgery, Zurich University Hospital & Dental School, Zurich


Abstract

In this study seventeen patients with neurofibromatosis in the maxillofacial region were presented. There was no great difference in the incidence of the disease between males and females. The patient age range was 1 to 75 years with a mean age of 21.5 years. Family history was positive in 5 cases. The spectrum of the clinical manifestations of this disease, known for its protean characteristics, were evident in all of our 17 patients. 14 (82.4%) patients had cafe'au-lait spots; 3 (1 7.6%) had multiple cutaneous nodules; malignant transformation was documented in only one case (5.9%). Psychologic depression was recorded in 2 (11.8%) ceases, and one(5.9%) case had grand-mal epilepsy. A rare location of neurofibromatous nodules, i.e. in eye (iris nodules), was reported in only one (5.9%) case. The most frequently performed procedure in our cases was excision of the tumor mass which was, in most instances, incomplete. However, massive bleeding during surgical intervention was prominent in four cases and was overcome with extensive packing removed after approximately two weeks. An interesting finding in this study was the incidence of radiologic findings which was higher (76.4%) than previously reported. All cases of this study were unilateral and involvement of the mandible (65%) was more than that of the maxillae.


Introduction

Neurofibromatosis was first described by Akenside.1 However, Friedrich von Recklinghausen2 was the one who concluded that multiple tumors of nerves and skin (neuromas and fibromas) existed simultaneously and were structurally related, and
thus justified the name neurofibromatosis, which later became known as Recklinghausen's disease.
Recklinghausen's disease is an inherited disease transmitted as an autosomal dominant trait with a positive family history in most cases. It is considered to be one of the most devastating and destructive diseases in mankind.

 In addition to the associated skeletal lesions, neurocutaneous syndrome is characterized by
cutaneous and subcutaneous fibrous tumors of the skin, cafe'au-lait pigmentations, vascular and lymphatic anomalies, neurofibromas of the peripheral  and central nerves. These are in addition to the associated skeletal lesions.


Materials and Methods

  

The data for this study was gathered from seventeen patients with neurofibromas in the maxillofacial region. The patients were seen between 1970 and 1987 at the Department of Oral and Maxillofacial Surgery of the Zurich University Hospital.
Cases with inadequate information, or patients whose records could not be traced, were not
included in the study. When diagnosis was made, the patients were analyzed for age, sex, family history of the disease, associated complications and other dis­
eases. Evidence of malignant transformation, clinical site of neurofibromas, associated radiologic findings, and, finally, surgical procedures that were carried out for treating deformities caused by the disease were also noted.


Results

   

Age, Sex and Family History: 

Table 1 shows the ages of the seventeen patients when diagnosis was made. There was a wide age distribution from 1 to 75 years (mean: 21.5 years). However, the incidence of neurofibromas was slightly higher in females than males. Ten (58.8%) were females and seven (41.2%) were males.

There was positive family history in five patients (29.4%) as shown in Table 1. Types of complications and other associated lesions seen in these patients are presented in Table 2 and they were as follows:

  1. Cafe au lait spots, an important diagnostic sign in neurofibromatosis were found in 14 (82.4%) patients.
  2. Multiple cutaneous nodules' were seen in three (17.6%) patients.
  3. Evidence of malignancy was found in only one (5.9%) patient and this malignancy was reported histopathologically as leiomyosarcoma.
  4. Four (23.5%) patients had mental retardation.
  5. One case had grand-mal epilepsy.
  6. Psychologic depression, a social problem in patients with this disease, was noticed in two (11.8%) patients.
  7. Hemorrhage, a difficult operative problem, was encountered in four (23.5%) cases.
  8. Iris nodules were reported in one (5.9%) case.

Clinical Sites:

The distribution of the lesions in various anatomical sites is shown in Table 3. All cases of this study were involved unilaterally. The tumor masses affected one or several anatomical locations. However, the lower jaw was involved in 11 (64.7%) out
of the seventeen cases.

Upper jaw lesions were recorded in nine (52.9%) cases. Lips were deformed in six (35.3%) patients. Tumor mass in the nose was evident in
two (11.8%) patients. Cheek was disfigured with hyperplastic masses of the tumor in six (35.3%) patients. Orbit and eyelids were involved in three (17.6%) patients. Unilateral macroglossia was evident in two (11.8%) cases while deformity of the
ear was present in one (5.9%) patient.


Radiologic Findings:

Radiologic findings of this series are listed in Table 4, and skeletal manifestations, in some cases,
are illustrated in Figs. 1 to 4. Skeletal involvements associated with the tumor masses were encountered in 13 (76.4%) cases. These cases were
reported as bony changes in the maxilla, clinically presenting as hypoplasia of the maxilla and maxillary sinus 6 (35.3 %), dental impaction, spacing and displacement of the teeth 5 (29.4%), and outwardly curvature of the zygomatic arch 2(11.8%)

In the mandible the bony changes were found in 12 (70.6%) cases. They were recorded as: hypoplasia and flattening of the contour 10 (58.8%), small condyle and flat glenoid fossa 7 (41.1%), obtuse gonial angle 8 (47.1 %), large funnel-shaped inferior dental canal opening 6 (35.3%), large mental foramen 1 (5.9%), increased depth of the sig­
moid notch 7 (41.1 %), deviation of the mandible 5 (29.4%), intra-osseous cystic formation 6(35.3%), spacing, impaction and displacement of the teeth 10(58.8%).

Orbital involvements were noticed in two (11.8%) cases. The characteristic changes seen were enlargement of the orbit in one (5.9%) case and hypoplastic deformity of the lateral wall, floor, and inferior rim in another case (5.9%)

 

Surgical Management:

Methods used in the surgical management of these patients are listed in Table 5.The most frequent operative procedure was excision of the tumor mass. Incomplete excision of the tumor lesions was carried out in 11 (84.6%) patients. Complete removal of the mass was done in five (31.3%) patients. One patient failed to present for surgical treatment after being scheduled.

Dental extraction of impacted teeth or surgical release of fibrous hyperplastic tissue from crowns of teeth was carried out on seven (43.8%) cases.

Surgical correction of the facial or occlusal asymmetry included sagittal splitting, genioplasty, and LeFort I osteotomy, in three (17.6%), two (12.5%),
and one (6.3%) patient(s), respectively.

Correction of the nose was performed in one (6.3%) case. Two (12.5%) patients had undergone partial glossectomy for removal of unilateral hyperplastic tissue. One (6.3%) case had radical neck dissection because of evidence of malignant transformation. Parotidectomy was done in one (6.3%) case. Face lifting and eyebrow lifting for improved cosmetic outcome were performed in two (12.5%) cases.

Overcoming spontaneous massive hemorrhage during surgical intervention was achieved in four (23.5%) cases by application of massive packing at the operative site. The tamponade was removed or renewed after approximately two weeks.

   

Discussion

  

Neurofibromatosis is, by no means, a rare disease although it is not a very common one.It is probably the most common genetic disease in mankind.3 The incidence is recorded in most of the reports as 1 in 3000 live births.4, 5, 6. The age distribution of patients in this study is in the same range reported by others.7, 8. There appears to be no significant difference in the inci­ dence of disease between males and females in this series. In most of the previous reports, the sex ratio was approximately equal.5, 9

Family history may be detected in some instances, and, in our study, it was positive in 5 (29.5%) cases. Other reports have shown inherited transmission in 10 to 50 percent of cases.8,10. The presence of cafe'au-lait spots ordinarily may be normal, but association of clinical and skeletal lesions is considered to be a characteristic diagnos­ tic feature of neurofibromatosis.11

These cutaneous brown spots were found in 14 (82.4%) of our cases in agreement with previous reports.11, 12. Multiple cutaneous nodules are mainly found after puberty and are usually manifestations of long standing or adult disease.13, 14. They were recorded in only 4 of our patients.  Maceri and Saxon9 reported that 66.6% of their 63 patients had these nodules, whereas Crawford12 found only 18% of his 116 children with neurofibromatosis nodules.

Incidence of malignancy is rare with neurofib­ romatosis, although it is, beyond question, part of the disease considerations. It is recorded in only one case of our group. Others8, 15, 16, 17 found malignant frequency of between two and five percent. Mental retardation in patients with neurofibromatosis18 was associated with four of our patients. Psychologic depression10 is a problem of patients with neurofibromatosis due to isolation from the surrounding society. Two of our patients suffered from this problem. Other clinical findings reported by others,10, 19 which we also found in our series, were grandmalepilepsy and iris nodules (one case each).

Hemangiomatous and lymphangiomatous mal­ formations in neurofibromatous lesions are
anomalies of vascular and lymphatic systems con­ tributory to massive bleeding.20-26 However, in our study, four patients did show this problem and
were managed without difficulty. Preliminary ligation of feeding vessels was not considered by us, as advocated by some authors,26 since the procedure increases vascularity by opening up the collateral vessels.

Adekeyeetal17 used boiling water as a sclerosing agent. This caused operative difficulty and post-operative hematoma in 7 of their 28 patients. Intra­ arterial embolisation by introducing strips of lyophilized dura into the main feeding vessels was recommended by Littlewood and Stillwell.27. Frame et al28 suggested the use of Gelfoam and Polyvinyl sponges as embolising agents. However, extensive tamponment packing was used to over­
come spontaneous massive hemorrhage in our cases. It was left in the operative site and removed after approximately two weeks without significant post-operative bleeding. Pressure dressing was applied to reduce post-operative hematoma. The neurofibromatous changes of this series were exclusively unilateral, whereas Vincent and Williams29 reported a rare case of bilateral involvement.

In contrast to the report of Koblin and Reil,25 the lower jaw was the most involved site in our patients (11 out of 17 cases). Occlusal plane distortion and facial asymmetry are common findings with this disease14, 16, 30 and were noticed in 8 of our patients. Tongue is a common site for neurofibromatous lesions,6, 22, 31-32 and two of our patients
presented with unilateral macroglossia. Hyperplastic deformities of other common sites, as reported by other authors,21, 32 were also encountered in this series in the palate and alveolar process, lips, nose, cheek, orbit, and ear. Rather surprisingly, skeletal
lesions were associated with 76.4% of our cases whereas other comparable studies4, 6, 7,9 reported bone lesions in the range of 18-70% of the cases.

All skeletal deformities of our cases were of hypoplastic features. Several authors9, 25, 33-35 drew attention to deformities of the facial bones in patients with neurofibromatosis as hypertrophy, hypoplasia, asymmetry, and radioluscent defects. However, the bony defects in this study which had been reported in various previous studies were recorded as hypoplasia of the maxilla and maxillary sinus, maxillary teeth impaction and spacing,16 hypoplasia of the zygoma with prominent convex­ ity of the zygomatic arch,36 mandibular hypoplasia with flat contour, 14small size of the mandibular condyle and flatness of the glenoid fossa,37 obtuse gonial angle, large funnel-shaped opening of the inferior dental canal, enlargement of the mental foramen,38 increased depth of the sigmoid notch,35 intra-osseous cystic radiolucencies,4, 39, 40, 41 deviation of the mandible,34 mandibular teeth impaction and spacing,25 enlargement of the orbit, and hypoplastic deformities of the lateral wall, floor, and inferior rim.33, 38, 42, 43

As yet there are no means of curing or even arresting neurofibromatosis, it is generally recommended that deforming, or symptomatic lesional tissue masses, be surgically removed electively. In doing this, the benefit of surgical resection must be weighed against the final aesthetic result and the function preserved. Shack and associates44 recommended total excision when feasible, and judicious subtotal extirpa­ tion when vital structures are involved, or when
total excision would produce considerable defor­ mity. However, the most frequently performed procedure in our cases was excision which was, in most instances, incomplete.

   

Reference


  1. Akenside M. Observation on cancers. Med Trans Coll PhysLond 1768;1:64.
  2. Von Recklinghausen FD, Uber die multiplen fibrome der haut und ihre beziehung zu den multiplen neuromen. Festschrift fur Rudolph Virchow,Berlin,Hirschwald, 1882.
  3. Stewart RE, Prescott GH (editors). Oral facial genetics. St. Louis, The Mosby Company 1976;615-618.
  4. Hunt JC, Pugh DG. Skeletal lesions in neurofibromatosis. Radiology 1961;76:1-20.
  5. Hope DG, Mulvihill JJ. Malignancy in neurofibromatosis. Adv Neurol 1981;29:33-56.
  6. Shapiro SD et al. Neurofibromatosis: Oral and radiog­ raphic manifestations. Oral Surg 1984;S8(4):493-498.
  7. AdekeyeEO, AbioseA, Ord RA. Neurofibromatosis ofthe head and neck: Clinical presentation and treatment.) Maxillofac Surg 1984;12:78-85.
  8. Griffith BH, Lewis VL, McKinney P. Neurofibromatosis of the head and neck. Surg GynObst 1985;160:534-538.
  9. Maceri DR, Saxon KG. Neurofibromatosis ofthe head and neck. Head and Neck Surg 1984;12(2):78-85.
  10. Crowe FW, Schull WJ, Neil JW. A clinical, pathological and genetic study of multiple neurofibromatosis. Springfield, III.: Charles C. Thomson, 1956.
  11. Crowe FW, Schuli WJ. Diagnostic importance of cafe'au-lait spots in neurofibromatosis. Arch Intern Med 1953;91:758-766.
  12. Crawford AH. Neurofibromatosis in children. Acta Orthopaed Scand Sup I986;2l8(51):1-60.
  13. O'Driscoll P. The oral manifestations of multiple neurofib­ romatosis. BrJ Oral Surg 1965;3:22-31.
  14. lames PL, Treggiden R. Multiple neurofibromatosis associated with facial asymmetry. J Oral Surg 1975;33:439-442.
  15. Yaghmai I, Tafazoli M. Massive subperiosteal hemorrhage in neurofibromatosis, Radiology 1977;122:439-441.
  16. Badger GR. Solitary neurofibromatosis in the maxilla: Report of oral findings. J Am Dent Assoc 1980;100:213-4.
  17. Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol 1981;29:57-65.
  18. Chao DHC. Congenital neurocutaneous syndromes in childhood: I, Neurofibromatosis. J Pediat 1959;55:189-199.
  19. Inster MS, Helm C, Napoli, S. Congenital hamartoma in neurofibromatosis. AM J Oph 1985;99(6):731-33.
  20. Goetsch E. Schadelveranderungen bei Neurofibromatose Recklinghausen. Fortsche. Rontgenstra 1955;83:225-9.
  21. Kragh LV, Soule EH, Masson JK. Neurofibromatosis (Von Recklinghausen's disease) of the head and neck: Cosmetic and reconstructiveaspects. Plast Recons Surg 1960;25(6):565-573.
  22. Wannenmacher MF, Becker. Orale Manifestation der Neurofibromatose Recklinghausen. Dtsch Zahnarztl Z 1969;24:976 982.
  23. Sailer HF. Mandibular asymmetry associated with perimandibular hemangiomas. J Maxillofac Surg 1973;104:109.
  24. Mukherji MM. Giant neurofibroma of the head and neck. Plast and Recon Surg l974;53:184.
  25. Koblin I, Reil B. Changes in facial skeleton in cases of neurofibromatosis. J Maxillofac Surg 1975;3:23-7.
  26. Berggren RB, Mohier LR, Ferraro JW. Excision of massive hemangio- neurofibroma of the face. Plast and Recon Surg 1976;58(4):444-9.
  27. Littlewood AHM, Stilwell JH, The vascular features of plexiform neurofibroma with some observations on the importance of pre-operative angiography and the value of preoperative intra-arterial embolisation. Br J Plast Surg 1983;36:501-506.
  28. Frame JW et al. Therapeutic arterial embolisation of vascu­ lar lesions in the maxillofacial region. Br J Oral Maxillofac Surg1987:25:181-194.
  29. Vincent SD, Wiliams TP. Mandibular abnormalities in neurofibromatosis. Oral Surg 1983;55(3):253-8.
  30. Freedus MS, Doyle PK. Multiple neurofibromatosis with oral manifestations. J Oral Surg 1975;33:360-363.
  31. Epstein JB, Schubert MM, Hatcher DC. Multiple neurofib­ romatosis. Oral Surg 1983;56(5):560-562.
  32. Baden E et al. Neurofibromatosis of the tongue: A light and eiectron microscopic study with review of the literature from 1849-1981. J Oral Med 1984;39(3): 157-164.
  33. Meulen J. Orbital neurofibromatosis. Clin Plast Surg l987;14(l):l23-35.
  34. Moore BH. Some orthopaedic relationships of neurofib­ romatosis. J Bone Joint Surg 1941;23:109.
  35. Muller H, Slootweg P. Maxillofacial deformities in neurofibromatosis. J Maxillofac Surg 1981 ;9:89-95.
  36. Gupta SK, Kaur S, Sharma OP. Craniofacial neurofib­ romatosis: A Roentgen Profile. Australas Radiol 1984;28:97-105.
  37. Lorson EL et al. Neurofibromatosis with central neurofib­ romas of the mandible: Review ofthe literature and report of a case. J Oral Surg 1977;35:733-738.
  38. Gupta SK et al. The radiological features of craniofacial neurofibromatosis. Clin Radiol 1979;30:553-557.
  39. Holt JF, Wright EM. The radiologic features of neurofib­ romatosis. Radiology 1948;51:647-664.
  40. Henstey CD. Rapid development of subperiosteal bone cyst in multiple neurofibromatosis: Case report. J Bone and Joint Surg 1953; 35 -A:197-203.
  41. Burrows EH. Orbitocranial asymmetry. Br J Radiol 1978;51:771-781.
  42. Jackson IT, Laws ER, Martin RD. The surgical manage­ ment of orbital neurofibromatosis. Plas Recons Surg 1983;71(6):75l-758.
  43. Zimmermann RA et a!. Computed tomography of orbital facial neurofibromatosis. Radiology 1983; 146:113-116.
  44. Shack RB, Reilley AF, Lynch JB. Neurofibroma of the head and neck. South-Med J 1985;78(7):80l-4.  

Address reprint requests to:

Dr. K.A. Al-Ruhaimi,
Dept. of Biomedical Dental Sciences,
College of Dentistry, King Saud University,
P.O. Box 60169, Riyadh 11545,
Kingdom of Saudi Arabia

 
Tables



1989-1-3-1


1989-1-3-2


1989-1-3-3


1989-1-4-1


1989-1-4-2


1989-1-4-3


1989-1-4-4


1989-1-5-1

1989-1-5-2

 

 
Website designed and maintained by DeltaCAS